Clinical Trial Update: HDI Versus Chemotherapy as Systemic Adjuvant Therapy for Resected Mucosal Melanoma [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing HDI to chemotherapy as adjuvant systemic therapy for resected mucosal melanoma is ongoing with an unknown status.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Drugs mentioned

• HDI

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Melanoma | Phase 3 | Status: UNKNOWN